6 Results

People

  1. Landgren
    Landgren
  2. Hassoun
    Hassoun
  3. Korde
    Korde
  4. Landau
    Landau
  5. Lesokhin
    Lesokhin
  6. Mailankody
    Mailankody
  7. Carroll
    Carroll
  8. Chapman-Lim
    Chapman-Lim
  9. Chung
    Chung
  10. Ciardiello
    Ciardiello

Groups

  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Myeloma (6)
  5. Hematologic Malignancies Research (5)
  6. Survivorship Research (3)
  7. Bone Marrow Transplant (2)
  8. Sloan Kettering Institute Postdocs (2)
  9. CTCR Scholars (1)
  1. "m protein"
  2. "Journal article"
  3. "Myeloma"
Formats
  1. Journal Article (6)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Myeloma (6)
  5. Hematologic Malignancies Research (5)
  6. Survivorship Research (3)

More Groups

People
  1. Carl Landgren (5)
  2. Hani Hassoun (3)
  3. Alexander Lesokhin (2)
  4. Heather Landau (2)
  5. Neha Korde (2)
  6. Sham Mailankody (2)

More People

Years
  1. 2020 (2)
  2. 2018 (1)
  3. 2014 (2)
  4. 2012 (1)
Publications
  1. Blood (1)
  2. British Journal of Haematology (1)
  3. Clinical Biochemistry (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Haematologica (1)
  6. Journal of Molecular Diagnostics (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Society of Hematology (1)
  3. Elsevier Science, Inc. (1)
  4. Ferrata Storti Foundation (1)
  5. John Wiley & Sons (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
    Journal Article

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Lu, S.; Shah, U.; Hassoun, H.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Mass spectrometry-based method targeting Ig variable regions for assessment of minimal residual disease in multiple myeloma
    Journal Article

    Martins, C. O.; Huet, S.; Yi, S. S.; Ritorto, M. S.; Landgren, O.; Dogan, A.; Chapman, J. R.
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
    Journal Article

    Murata, K.; McCash, S. I.; Carroll, B.; Lesokhin, A. M.; Hassoun, H.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Landau, H. J.; Koehne, G.; more...
    Clinical Biochemistry (2018)

    Fulltext@MSK | Save
  • How I treat smoldering multiple myeloma
    Journal Article

    Ghobrial, I. M.; Landgren, O.
    Blood (2014)

    Fulltext@MSK | Save
  • A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
    Journal Article

    Korde, N.; Carlsten, M.; Lee, M. J.; Minter, A.; Tan, E.; Kwok, M.; Manasanch, E.; Bhutani, M.; Tageja, N.; Roschewski, M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis
    Journal Article

    Zhou, P.; Hoffman, J.; Landau, H.; Hassoun, H.; Iyer, L.; Comenzo, R. L.
    Clinical Lymphoma, Myeloma and Leukemia (2012)

    Fulltext@MSK | Save